Ba. Finette et al., V(D)J RECOMBINASE-MEDIATED HPRT MUTATIONS IN PERIPHERAL-BLOOD LYMPHOCYTES OF NORMAL-CHILDREN, Cancer research, 56(6), 1996, pp. 1405-1412
Somatic mutations in the hypoxanthine-guanine phosphoribosyltransferas
e (hprt) gene are rare occurrences in T-lymphocytes of normal individu
als. Lacking pathogenic significance, these events can serve as report
ers for assessing environmental genotoxicity. The present molecular an
alyses of hprt mutations arising spontaneously in normal children show
that 30-35% of the genomic hprt changes in children under 5 years of
age have similar to 20 Kb deletions encompassing exons 2 and 3. The fr
equency of these specific changes are dramatically decreased in older
children. Sequence analysis of these deletion breakpoint and joining r
egions reveal the molecular hallmarks of V(D)J recombinase-mediated re
combination events. This early childhood hprt mutational spectrum is q
uite distinct from the adult background spectrum but similar to that r
eported previously for newborns, as determined in lymphocytes from pla
cental cord blood. The present study also demonstrates that definition
of sequences in the hprt deletion joining regions that are analogous
to the N-nucleotide insertion hypervariable regions of rearranged T-ce
ll receptor genes allows the same identification of in vivo clonality
of mutants as does analysis of the T-cell receptor gene rearrangements
themselves. These methods reveal an in vivo clonal amplification of a
V(D)J recombinase-mediated hprt mutant clone in one child in the pres
ent study. This newly found age-frequency distribution of V(D)J recomb
inase-mediated hprt mutations correlates with the age-frequency distri
bution of childhood acute lymphocytic leukemia. A significant number o
f these malignancies, including acute T-cell leukemia, are also charac
terized by V(D)J recombinase-mediated recombinations but in critical r
egions of the genome, hprt, therefore, captures a pathogenic mutagenic
mechanism as a harmless mistake which, when it occurs in other geneti
c regions, may result in malignancy.